Nasdaq:US$40.98 (-0.83) | HKEX:HK$70.85 (-6.75) | AIM:£5.92 (+0.14)
Search Result
Previous Article   |   Next Article
Announcements & Press Releases, Oncology / Immunology | 6 Jun 2012

Hutchison MediPharma Limited Announces Presentations of Sulfatinib and Fruquintinib Clinical Data at the 2012 ASCO Annual Meeting